127 related articles for article (PubMed ID: 21061792)
41. Weekly paclitaxel and nedaplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a phase I/II study.
Hasegawa Y; Takanashi S; Okudera K; Aoki M; Basaki K; Kondo H; Takahata T; Yasui-Furukori N; Tateishi T; Abe Y; Okumura K
Jpn J Clin Oncol; 2004 Nov; 34(11):647-53. PubMed ID: 15613553
[TBL] [Abstract][Full Text] [Related]
42. Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days.
Sessa C; Minoia C; Ronchi A; Zucchetti M; Bauer J; Borner M; de Jong J; Pagani O; Renard J; Weil C; D'Incalci M
Ann Oncol; 1998 Dec; 9(12):1315-22. PubMed ID: 9932162
[TBL] [Abstract][Full Text] [Related]
43. Randomized phase 3 trial comparing 2 cisplatin dose schedules in 326 patients with locally advanced squamous cell cervical carcinoma: long-term follow-up.
Nagy VM; Ordeanu C; Coza O; Alin CR; Traila A; Todor N
Int J Gynecol Cancer; 2012 Nov; 22(9):1538-44. PubMed ID: 23070071
[TBL] [Abstract][Full Text] [Related]
44. [Phase I study of a combination chemotherapy of nedaplatin and cisplatin].
Nishida M; Satoh Y; Nishide K; Tsunoda H; Kubo T
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2209-15. PubMed ID: 10635306
[TBL] [Abstract][Full Text] [Related]
45. Concomitant irradiation and dose-escalating carboplatin for locally advanced carcinoma of the uterine cervix: an updated report.
Corn BW; Micaily B; Dunton CJ; Heller P; Valicenti RK; Anderson L; Hernandez E
Am J Clin Oncol; 1998 Feb; 21(1):31-5. PubMed ID: 9499253
[TBL] [Abstract][Full Text] [Related]
46. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
[TBL] [Abstract][Full Text] [Related]
47. The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer.
Vermorken JB
Int J Gynecol Cancer; 2001; 11 Suppl 1():21-30. PubMed ID: 11488999
[TBL] [Abstract][Full Text] [Related]
48. [Chemotherapy by superselective intraarterial infusion of nedaplatin combined with radiotherapy for oral cancer].
Yamashita Y; Goto M; Katsuki T
Gan To Kagaku Ryoho; 2002 Jun; 29(6):905-9. PubMed ID: 12090042
[TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
Niioka T; Uno T; Yasui-Furukori N; Takahata T; Shimizu M; Sugawara K; Tateishi T
Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
[TBL] [Abstract][Full Text] [Related]
50. Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysis.
Petrelli F; De Stefani A; Raspagliesi F; Lorusso D; Barni S
Gynecol Oncol; 2014 Jul; 134(1):166-71. PubMed ID: 24793000
[TBL] [Abstract][Full Text] [Related]
51. Nedaplatin and 5-FU combined with radiation in the treatment for esophageal cancer.
Yamanaka H; Motohiro T; Michiura T; Asai A; Mori T; Hioki K
Jpn J Thorac Cardiovasc Surg; 1998 Oct; 46(10):943-8. PubMed ID: 9847566
[TBL] [Abstract][Full Text] [Related]
52. Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy in the treatment of cervical cancer: a meta-analysis result.
Hu Y; Cai ZQ; Su XY
Asian Pac J Cancer Prev; 2012; 13(9):4301-4. PubMed ID: 23167332
[TBL] [Abstract][Full Text] [Related]
53. A dose-finding study of nedaplatin and cyclophosphamide for patients with gynecological malignancies.
Ito K; Adachi S; Itani Y; Koyama M; Hori K; Chin R; Shintani M; Beppu K; Kawai S; Saito K
Jpn J Clin Oncol; 1999 Jun; 29(6):299-302. PubMed ID: 10418559
[TBL] [Abstract][Full Text] [Related]
54. [Clinical study of the combination of small amount of nedaplatin (CDGP)/5-FU with radiation for the treatment of esophageal cancer].
Inaba H; Tsuda T; Miyazaki A; Watanabe Y; Nakaya S; Koitabashi Y; Ogihara K; Hara T; Kato N; Kobayashi Y; Nakagawa T; Kitajima S; Endo T; Iino S; Hoshikawa Y
Nihon Shokakibyo Gakkai Zasshi; 2002 Oct; 99(10):1191-6. PubMed ID: 12415854
[TBL] [Abstract][Full Text] [Related]
55. [Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer].
Zhang P; Xie CY; Wu SX
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):773-7. PubMed ID: 18396692
[TBL] [Abstract][Full Text] [Related]
56. [Clinical trial of chemotherapy by superselective intra-arterial infusion of nedaplatin combined with radiotherapy for advanced oral cancer].
Yamshita Y; Shikimori M; Goto M
Gan To Kagaku Ryoho; 2005 Sep; 32(9):1267-71. PubMed ID: 16184922
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetic and pharmacodynamic analysis of bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) administered once a day for five consecutive days: a phase I study.
Kurata T; Tamura T; Sasaki Y; Fujii H; Negoro S; Fukuoka M; Saijo N
Jpn J Clin Oncol; 2000 Sep; 30(9):377-84. PubMed ID: 11095134
[TBL] [Abstract][Full Text] [Related]
58. Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.
Yamamoto K; Iwahana M; Kumazawa E; Kakihata K; Abe K; Hirano F; Tohgo A; Hoshiai H; Noda K
Oncol Rep; 2003; 10(3):593-8. PubMed ID: 12684629
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
Welink J; Boven E; Vermorken JB; Gall HE; van der Vijgh WJ
Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
[TBL] [Abstract][Full Text] [Related]
60. [Clinical phase trial of concurrent chemoradiotherapy combined TS-1 and nedaplatin].
Takemura H; Kobayashi S; Katsuno M; Asano R; Morimoto M; Tachibana S; Kubota H; Iida M; Kadokura Y; Sanbe T
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2065-9. PubMed ID: 16352930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
